close

Amanda L. Rose

Associate, Corporate  

Seattle 206.389.4553

Overview

​Amanda Rose focuses her practice on corporate finance and securities, mergers and acquisitions and general corporate matters for public company clients. Amanda has represented issuers and underwriters in numerous securities offerings by public companies across several industries, including communications, Internet, software, health information services, natural resources and network security. She also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters.

​Amanda’s recent capital market transactions have included:

  • Castlight Health’s strategic investment from SAP
  • Facebook’s $18 B initial public offering
  • LendingClub’s $1 B initial public offering
  • Symantec’s $1 B senior notes offering
  • Chegg’s initial public offering
  • Tableau Software’s $292 M initial public offering (represented the underwriters)
  • ProNAi Therapeutics’ $158.4 M initial public offering
  • Vocera Communication’s $139 M follow-on offering
  • Model N’s $120 M initial public offering
  • Trupanion’s $71.3 M initial public offering
  • Cascadian Therapeutics’ $50 M ATM
  • OncoGenex Pharmaceutical’s $50 M follow-on offering and $25 million at-the-market offering
  • Meru Networks’ $12 M shelf offering
  • Cascadian Therapeutics’ $10 M registered direct offering

Prior to joining Fenwick & West, ​Amanda was an associate in the Corporate Group at Dorsey & Whitney LLP. Her capital market transactions while at her prior firm included:

  • $1 B concurrent private offering of high yield debt and public offering of common stock of a large oil and gas company
  • $900 M 144A note offering of a large petroleum company
  • $167 M public offering of common stock of a large oil and gas company
  • $158 M public offering of common stock of a large oil and gas company
  • $80 M public offering of common stock of a large oil and gas company
  • $75 M public offering of common stock of a gold mining company
  • $50 M public offering of common stock and warrants of a pharmaceutical company

​While in law school, ​Amanda was Associate Editor for the Seattle University Law Review.​